Skip to main content
. Author manuscript; available in PMC: 2020 Jul 24.
Published in final edited form as: J Am Chem Soc. 2019 Jul 9;141(29):11721–11726. doi: 10.1021/jacs.9b06229

Figure 6.

Figure 6.

Serum stability of the nanostructure. A) 100 nM anti-Digoxigenin (+) spiked into undiluted serum (resulting in 90 % serum) and in buffer showed similar signal suppression levels. In the absence of anti-digoxigenin (−) the undiluted serum and buffer did not undergo observable signal changes. B) 50 nM tacrolimus (+) mixed with 15 nM antibody was spiked into undiluted serum and in buffer, then compared to controls with only antibody (−). Expected trends for the competitive assay were observed, albeit with some matrix effects.